Answers are grounded in this paper and cite their sources.
Prenatal arsenic exposure has been linked to a myriad of negative health effects. There is relatively little insight into the mechanisms and signaling alterations across different fetal organs that drive long-term immune-related issues following prenatal arsenic exposure. Therefore, the effects of this exposure window on gene expression in the liver, placenta, heart, and lung of gestation day (GD) 18 C57BL/6 mouse fetuses were investigated. From two weeks prior to mating until tissue collection at GD18, mice were exposed to 0 or 100 ppb sodium (meta) arsenite in drinking water, ad libitum . Genes of interest were analyzed by RT-qPCR, complemented with untargeted Agilent 44 K microarray analysis. Data cleanup and analysis was performed in RStudio. Differentially expressed mRNAs were queried in the String Database and using Cytoscape to create interaction networks and identify significantly enriched biological pathways. A total of 251, 165, 158, and 41 genes were significantly altered in the liver, placenta, heart, and lung, respectively, when treated samples were compared to controls. Many altered pathways were immune-related, supporting prior research. Most notably, gene expression of Gbp3 , a key player in the cellular response to interferon gamma ( Tretina et al. 2019 ), was found to be reduced in placentas of male fetuses exposed to arsenic compared to controls ( p =0.0237). This is the first study comparing alterations in gene expression across multiple organs following prenatal exposure to environmentally relevant levels of arsenic. These findings, elucidating the multi-organ impact of prenatal arsenic exposure on predominantly immune-related pathways, further our mechanistic understanding of the long-term health effects observed in early-life arsenic-exposed populations. Fig. 8. Prenatal arsenic exposure and gene expression changes in fetal organs. Graphical abstract: Female C57BL/6 J mice were exposed to inorganic arsenic (iAs) in drinking water during pregnancy, followed by tissue collection at gestation day (GD) 18 from fetal liver, heart, lung, and placenta. Gene expression was assessed using RT-qPCR and untargeted Agilent 44 K microarray profiling, with downstream bioinformatics and network/pathway enrichment analyses (STRING queried and visualized in Cytoscape). Prenatal arsenic exposure resulted in differential mRNA expression across all organs, with 251 altered genes in liver, 165 in placenta, 158 in heart, and 41 in lung compared with controls. Altered pathways were predominantly immune-related, and placentas from male fetuses showed reduced expression of guanylate-binding protein 3 ( Gbp3 ) expression in placenta ( p =0.0237) when comparing male arsenic-exposed placentas to controls.
No takes yet. Share an insight, caveat, or question.
Rychlik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: